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ABSTRACT 
Heterotrimeric G proteins play a pivotal role in GPCR signalling; they link receptors to intracellular 
effectors and their inactivation by RGS proteins is a key factor in resetting the pathway following 
stimulation. The precise GPCR:G protein:RGS combination determines the nature and duration of 
the response. Investigating the activity of particular combinations is difficult in cells which contain 
multiples of each component. We have therefore utilised a previously characterised yeast system to 
express mammalian proteins in isolation. Human Gαq and Gα11 spontaneously activated the yeast 
pheromone-response pathway by a mechanism which required the formation of Gα-GTP. This 
provided an assay for the specific activity of human RGS proteins. RGS1, RGS2, RGS3 and RGS4 
inhibited the spontaneous activity of both Gαq and Gα11 but, in contrast, RGS5 and RGS16 were 
much less effective against Gα11 than Gαq. Interestingly, RGS2 and RGS3 were able to inhibit 
signalling from the constitutively active GαqQL/Gα11QL mutants, confirming the GAP-independent 
activity of these RGS proteins. To determine if the RGS-Gα specificity was maintained under 
conditions of GPCR stimulation, minor modifications to the C-terminus of Gαq/Gα11 enabled 
coupling to an endogenous receptor. RGS2 and RGS3 were effective inhibitors of both Gα subunits 
even at high levels of receptor stimulation, emphasising their GAP-independent activity. At low 
levels of stimulation RGS5 and RGS16 retained their differential Gα activity, further highlighting 
that RGS proteins can discriminate between two very closely related Gα subunits. 
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1.  INTRODUCTION 
G protein-coupled receptors (GPCRs) are a diverse family of integral membrane proteins that 
enable cells to respond to a wide variety of extracellular signals. The receptors act through 
heterotrimeric G proteins composed of Gα, Gβ and Gγ subunits. In unstimulated cells the Gα 
subunit is bound to GDP and associated with the Gβγ dimer. An activated receptor stimulates the 
exchange of GDP for GTP and the Gα-GTP and Gβγ subunits regulate the activity of effector 
proteins to bring about changes in cell behaviour. One mechanism that contributes to the recovery 
of the cell following stimulation involves regulator of G protein signalling (RGS) proteins that act 
as GTPase-activating proteins (GAPs) for Gα-GTP, leading to the formation of Gα-GDP and 
reassociation of the inactive heterotrimer. 
The relative simplicity of the GPCR-Gαβγ-RGS signalling unit belies a diversity of function. 
The human genome encodes approximately 360 non-sensory GPCRs (and a similar number of 
olfactory and gustatory receptors), 16 Gα subunits, 5 Gβ subunits, 12 Gγ subunits and at least 20 
RGS proteins [1]. They are not all expressed in every cell type, but many cells express multiple 
examples of each component, and these can interact in various combinations to generate a multitude 
of different signalling pathways. It is the precise combination of GPCR, G protein, and RGS protein 
that determines which effectors are activated and for how long. This, in turn, determines the nature 
of the response to a particular stimulus. There is consequently a great deal of interest in identifying 
how GPCRs and RGS proteins target individual G proteins. 
While much information has been obtained regarding GPCR-Gα specificity, demonstrating 
RGS-Gα selectivity has proven more of a challenge. However, some RGS proteins have been 
shown to act in a restricted manner; for example, RGS-PX1 against Gαs [2], and RGS20 against 
Gαz [3]. Results for members of the Gαq family have been more difficult to achieve due to 
problems associated with the experimental measurement of Gαq GTPase activity. Despite this, 
sufficient evidence exists to suggest that RGS2, RGS3, RGS4, RGS18 and GAIP-RGS19 directly 
exhibit GAP activity toward Gαq [4]. Other RGS proteins (RGS1, RGS5, and RGS16) have been 
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demonstrated to bind Gαq, but their GAP activity has been difficult to establish [4]. We therefore 
sought to investigate the selectivity of the R4 family (RGS4-like) of RGS proteins against Gαq-
mediated signalling. Due to the presence of multiple components with overlapping functions within 
mammalian cells, we have employed a model organism. 
Yeast are an attractive system in which to analyse individual GPCR signalling pathways. 
Mechanisms of GPCR signalling in yeast are similar to those in higher eukaryotes but there are 
many fewer components and they can be easily manipulated. Most studies use the pheromone-
response pathway within the budding yeast Saccharomyces cerevisiae and have made a number of 
significant contributions to our understanding of GPCR signalling [5-7]. Although many 
components can be functionally replaced by their mammalian counterparts [8], few studies have 
reported the expression of non-yeast Gα proteins in Sc. cerevisiae [9-11]. This is primarily due to 
the Gα subunit in Sc. cerevisiae acting as a negative regulator of pheromone signalling (it is the 
Gβγ dimer that propagates the signal) [12] and, exchanging it with a human Gα which has low 
affinity for the yeast Gβγ will cause constitutive activation of the signalling machinery, leading to 
an arrest of the cell cycle.  
To allow investigation of mammalian Gα-signalling, we utilised a yeast in which the Gα is a 
positive effector of signalling [13]. The pheromone-response pathway of the fission yeast 
Schizosaccharomyces pombe provides an alternative system for analysing GPCR signalling, since 
strains have been modified to provide assays for G protein activation [14,15]. Studies in Sz. pombe 
have included isolation and characterisation of signal regulators [16], RGS proteins [14], and 
analysis of constitutively active receptors [17]. Non-yeast receptors have also been introduced into 
these strains and coupled to the pheromone-response pathway [15].  
Here we demonstrate that human Gαq and Gα11 are expressed in Sz. pombe. Both subunits 
activate the morphology-response pathway normally stimulated by the yeast Gα protein (Gpa1), 
providing an assay for their activity. We demonstrate that Gα signalling was dependent on GTP-
binding and that members of the R4 family of RGS proteins can selectivity inhibit Gαq- but not 
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Gα11-mediated signalling. Furthermore, expression of constitutively active versions of the Gα 
subunits illustrates that some RGS proteins are capable of modulating Gα signalling in a GAP-
independent manner. Finally, by modification of the last 5 residues of Gαq and Gα11, we have 
functionally coupled them to the yeast pheromone receptor, reconstituting the GPCR-Gα-RGS 
signalling unit and allowing RGS specificity against receptor-activated Gα proteins to be 
investigated. 
 
2. MATERIALS AND METHODS 
2.1 Strains, reagents and general methods - The yeast used in this study were derived from strain 
JY546 (mat1-M, ∆mat2/3::LEU2-, leu1-, ura4-D18, cyr1-D51, sxa2>lacZ) [16]. The gpa1  gene was 
disrupted in a two-step process in which the open reading frame (ORF) was first replaced with a 
1.8kb ura4+ cassette. JY1285 (mat1-M, ∆mat2/3::LEU2-, leu1-, ura4-D18, cyr1-D51, gpa1-D12, 
sxa2>lacZ) was subsequently generated by the removal of the ura4+ cassette from the gpa1 locus. 
A similar process was used to disrupt the rgs1 gene in JY1285 to generate JY1287 (mat1-M, 
∆mat2/3::LEU2-, leu1-, ura4-D18, cyr1-D51, gpa1-D12, rgs1-D14, sxa2>lacZ) and the mam2 gene 
in JY1287 to generate JY1286 (mat1-M, ∆mat2/3::LEU2-, leu1-, ura4-D18, cyr1-D51, gpa1-D12, 
rgs1-D14, mam2-D10, sxa2>lacZ). All gene replacements were confirmed by polymerase chain 
reaction (PCR) and Southern blot analysis. General yeast procedures were performed as described 
previously [18]; yeast extract medium was used for routine cell growth and defined minimal 
medium for selective growth and all assays. Cell concentrations and median cell volumes were 
determined using a Coulter Channelyser (Beckman Coulter, Luton, UK) [19]. DNA manipulations 
were performed by standard methods. Oligonucleotides were synthesised by TAG Newcastle Ltd. 
(Gateshead, UK). Amplification by PCR used Pwo DNA polymerase (from Pyrococcus woesei) 
(Boehringer Mannheim Biochemicals, Lewes, East Sussex, UK). All constructs generated by PCR 
were confirmed by sequencing. 
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2.2 Yeast expression constructs - The pREP series of Sz. pombe vectors allow expression of genes 
under the control of the thiamine-repressible nmt1  promoter [20]; pREP3X contains the LEU2 gene 
for nutritional selection and was used for expression of all Gα subunits, pREP4X contains the ura4 
gene and was used for expression of all RGS proteins. All wild-type ORFs were amplified by PCR 
and cloned into the pREP expression vectors. Sz. pombe genomic DNA was used as template for 
Gpa1 and Rgs1. All human ORFs were amplified using cDNA clones from the Guthrie cDNA 
Resource Center (www.cdna.org, University of Missouri at Rolla, USA). Most Gα mutants were 
produced by bipartite PCR on the wild-type constructs [21]. In this technique, two PCR reactions 
are performed on a plasmid containing the Gα ORF. Each PCR reaction amplifies approximately 
half of the target plasmid, from the site of mutagenesis in the Gα ORF to a site within the AmpR 
gene that confers ampicillin resistance on the host plasmid. Ligating the two PCR products in the 
correct orientation recreates the original vector, but containing the mutagenised Gα ORF. Human 
GαqQL and Gα11QL were cloned into the pREP3X expression vector as described for the wild-type 
ORFs. Gα-transplants were created by bipartite PCR; a Gα construct used as template for the major 
part of the protein and a Gpa1 construct as template for the C-terminal fragment. 
 
2.3 Immunoblotting - Cell extracts containing human Gα subunits and RGS proteins were prepared 
from duplicated cultures of Sz. pombe cells as described previously [17]. Protein concentration was 
determined using the Bio-Rad protein assay kit (Bio-Rad, Hemel Hempstead, Herts, UK). Samples 
containing equal amounts of protein were separated by polyacrylamide gel electrophoresis (PAGE) 
in the presence of sodium dodecyl sulphate (SDS) under standard conditions. Separated proteins 
were transferred to polyvinyl difluoride (Bio-Rad). Western blotting was performed using primary 
antibodies against the proteins of interest, and horseradish peroxidase-conjugated secondary 
antibodies (1:5000 dilution) were used to visualise bound primary antibodies by enhanced 
chemiluminescence reagents (ECL) (Amersham). All primary antibodies were supplied by Santa 
Cruz Biotechnology Inc. (Santa Cruz, California, USA) with the exception of RGS20 which was 
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supplied by Abcam Plc. (Cambridge, UK) and an anti-Gq antibody used for detection of Gq[5C] 
which was a gift from Professor Graeme Milligan (University of Glasgow). All secondary 
antibodies were supplied by Sigma-Aldrich Company Ltd (Poole, Dorset, UK). 
 
3. RESULTS 
3.1 Yeast reporter strains for assaying signalling activity of human Gα subunits - We have 
previously constructed Sz. pombe sxa2>lacZ reporter strains in which the chromosomal copy of the 
sxa2 ORF is replaced by the ORF of the bacterial lacZ gene (encodes β-galactosidase). Sxa2 is a 
carboxypeptidase that is only expressed following stimulation with the pheromone P-factor [22] and 
expressing lacZ under the transcriptional control of the sxa2  promoter provides a convenient 
readout for signalling through the pheromone-response pathway [16]. We sought to further modify 
this strain to provide a host for assaying human Gα subunits. The activity of a Gα subunit is 
regulated by interacting proteins. A stimulated GPCR induces the release of GDP from the Gα, 
forming Gα-GTP, while RGS proteins promote GTP hydrolysis to return the activated Gα to Gα-
GDP. Therefore, we removed not only Gpa1 (the endogenous Gα subunit) but also Mam2 (the P-
factor receptor) and Rgs1 (the RGS protein for Gpa1) (Fig. 1). The resulting strain (JY1286; 
∆mam2, ∆rgs1, ∆gpa1) had almost no signalling activity, as demonstrated by very low expression 
of β-galactosidase from the sxa2>lacZ reporter construct (Fig. 2A). 
 Expressing the Sz. pombe Gα subunit (Gpa1) in JY1286, from the thiamine-repressible nmt1 
promoter on the pREP3X plasmid [20], induced transcription of the sxa2>lacZ reporter (Fig. 2A). 
This is presumably caused by spontaneous nucleotide exchange on Gpa1, leading to signalling 
through the pheromone-response pathway. Such activation of Gα subunits in the absence of an 
appropriate receptor has been reported in both Sz. pombe [15,24] and Sc. cerevisiae [25,26], and is 
consistent with a role for unoccupied receptors in maintaining G proteins in their inactive state. It is 
likely that this spontaneous activity is accentuated by the absence of an RGS protein from our 
strain. 
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 We next investigated the ability of non-yeast Gα subunits to signal in JY1286. Mammalian 
Gα proteins are grouped into classes based upon structural and functional similarity. We initially 
chose to analyse prototypical members of the Gαq sub-family (Gαq and Gα11), as they are 
ubiquitously expressed, and couple to a wide range of GPCRs [4]. Expression of the Gα subunits in 
JY1286 was confirmed by immunoblotting and strains were assayed for induction of the sxa2>lacZ 
reporter (Fig. 2A). Gαq, but not Gα11, induced a low but reproducible level of β-galactosidase, 
demonstrating the first functional activity of a human Gα subunit in Sz. pombe.  
 
3.2 Shmoo formation - In addition to the transcription of pheromone-dependent genes, such as sxa2 
(the transcriptional response), Sz. pombe undergoes a change in cell morphology following 
pheromone stimulation. Responding cells continue to grow from the cell tip and elongate towards 
the source of the pheromone forming a shmoo [27,28]. Both pathways are mediated by Ras1 (Fig. 
1) and diverge immediately downstream of this molecular switch. Microscopic examination of 
JY1286 strains expressing Gαq or Gα11 revealed elongated cells reminiscent of shmoos (Fig. 2B). 
Cells cultured in the presence of thiamine, to repress expression of Gαq/Gα11, were not elongated, 
providing evidence that these Gα subunits can spontaneously activate the pheromone-response 
pathway leading to shmoo formation. 
 The increase in cell volume during shmoo formation provides a quantitative assay for 
signalling activity [19,28]. Briefly, because a non-synchronous culture contains cells of various 
sizes, it is not appropriate to monitor changes in individual cells. Instead, shmoo formation can be 
measured as an increase in the median cell volume of a culture. A strain lacking a Gα subunit had a 
median cell volume of ~63 fl (Fig. 2C). Expression of Gpa1 increased this to ~95 fl, and expression 
of either Gαq or Gα11 increased the median cell volume to greater than 80 fl (Fig. 2C). This 
demonstrates that both human Gα subunits can initiate the shmoo response in Sz. pombe. 
 To confirm that the responses in Fig. 2 were dependent upon the activated GTP-bound form 
of the Gα subunits, we constructed a series of Gα mutants and assayed their ability to signal in 
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JY1286 (Fig. 3). Mutation of a conserved glycine in the switch II region of Gα subunits inhibits the 
release of GDP and locks the Gα subunit in its inactive form [29]. The corresponding Gpa1IN 
mutant (containing a Gly243 to Ala mutation) was unable to induce either expression of the 
sxa2>lacZ reporter (Fig. 3A) or an increase in cell volume (Fig. 3B). Likewise, neither of the 
inactivated human Gα subunits GαqIN (Gly208 to Ala) (Fig. 3C) nor Gα11IN (Gly208 to Ala) (Fig. 3D) 
induced shmoo formation. 
 The activity of Gα subunits is regulated by RGS proteins that serve as GAPs for Gα-GTP. As 
demonstrated previously [14], Sz. pombe Rgs1 reduced the ability of Gpa1 to induce expression of 
the sxa2>lacZ reporter and prevented shmoo formation (Fig. 3A and 3B). This suggests that there is 
sufficient Rgs1 to ensure that almost all of the Gpa1 is in the inactive GDP-bound form. To confirm 
that the reduction in Gpa1 activity was due to the effect of Rgs1, we created a mutant Gpa1 
(Gpa1rgs) that was expected to have a much reduced interaction with RGS proteins. Mutation of a 
conserved glycine in the switch I region of Gα subunits (Gly223 in Gpa1) blocks the interaction with 
RGS proteins, but leaves intact the ability of Gα to couple to receptors and downstream effectors 
[30]. Gpa1rgs (containing a Gly223 to Ser mutation) activated both the transcription- and 
morphology-response pathways and was insensitive to co-expression of Rgs1 (Fig. 3A and 3B). 
 Expression of Sz. pombe Rgs1 markedly reduced the cell volume increase due to Gαq (Fig. 
3C) and Gα11 (Fig. 3D), suggesting that the yeast RGS protein can function as a GAP for human 
Gα subunits. This is not surprising as many RGS proteins function against more than one Gα 
subunit and, in a reciprocal arrangement, several mammalian RGS proteins have been shown to act 
as GAPs for GPA1 in the Sc. cerevisiae pheromone-response pathway [6]. However, this is the first 
demonstration that the Sz. pombe Rgs1 protein can function on human Gα subunits. We confirmed 
that the yeast Rgs1 protein directly reduced Gαq and Gα11 activity by constructing RGS-insensitive 
versions of the human subunits Gαqrgs (Gly188 to Ser) and Gα11rgs (Gly188 to Ser). These mutant Gα 
subunits displayed comparable activity in the presence or absence of Rgs1 (Fig. 3C and 3D). 
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3.3 Investigating the activity of human RGS proteins - Some 20 human RGS proteins have been 
identified and can be grouped into subfamilies based on sequence similarity [31]. The R4 family 
(those with similarity to RGS4) are the simplest in terms of structure, containing minimal protein 
motifs in addition to the signature RGS domain. Many R4 members can reduce signalling through 
Gαq/11-dependent pathways [4,31,32] but in vivo studies can be complicated by overlapping 
activities of the Gα subunits and RGS proteins, coupled to the technical difficulties in measuring 
GTPase activity associated with these G proteins. We therefore investigated whether the yeast-
based system could better define the interaction between the various Gα subunits and RGS proteins. 
 The strain JY1286 lacks Mam2, Rgs1 and Gpa1 and had a median cell volume of ~63 fl. This 
increased to ~85 fl following expression of Gαq and to ~83 fl following expression of Gα11 (Fig. 
2C). Using a second plasmid, which has previously been demonstrated to express proteins at levels 
equivalent to pREP3x [17], we co-expressed various human RGS proteins with Gαq (Fig. 4A) or 
Gα11 (Fig. 4B). Immunoblotting confirmed that each RGS protein was expressed to the same level 
in the presence of either Gαq or Gα11. RGS3 migrates as a larger species than the other RGS 
proteins due to expression of the long form of the protein (accession number: AAM12641). 
Determination of the median cell volume for each culture revealed that the RGS proteins reduced 
shmoo formation to different extents (Fig. 4C and 4D). To compare the Gα-RGS combinations, we 
normalised the results such that the cell volume in the absence of a Gα subunit (representing the 
minimum Gα activity that could be obtained) was set as 0% signalling, and the cell volume in the 
presence of Gα but the absence of an RGS protein (minimum RGS activity allowing maximum Gα 
signalling) was set as 100% signalling. The percentage signalling activity for each Gα in the 
presence of different RGS proteins was then calculated (Fig. 4E). All of the R4 RGS proteins tested 
reduced signalling by Gαq. In contrast, despite similar expression levels to the Gq strain, RGS16 
was unable to reduce signalling for Gα11, while RGS5 had an intermediate effects, reducing 
signalling to about 40% of that seen for Gα11 in the absence of an RGS. The differential effects of 
   11 
RGS16, and to a lesser extent RGS5, suggest that some RGS proteins can discriminate between 
these two highly related Gα subunits. 
 To further investigate the RGS specificity within the yeast system we assayed the ability of 
RGS20 to reduce signalling via Gαq and Gα11. RGS20 has previously been shown to be highly 
selective for Gαz and displays very low activity towards members of the Gαq/11 family [3]. Its 
inability to affect signalling of either Gαq or Gα11 in yeast is consistent with earlier work in other 
systems; experiments demonstrating that RGS20 completely inhibits signalling through the Sz. 
pombe Gpa1 confirm that the protein is functional in yeast (not shown). 
 
3.4 Inhibitory effect of RGS proteins on constitutively active Gα subunits - RGS proteins can reduce 
signalling through Gα-GTP by direct GAP activity and/or by acting as effector antagonists that 
inhibit the interaction of the Gα subunit with its downstream effector [33]. To examine whether the 
relative contribution of GAP and effector antagonistic effects differs among RGS proteins, we 
examined RGS activity under conditions where they cannot promote Gα-GTP hydrolysis. Mutation 
of Gln209 to Leu within the switch II region of both Gαq and Gα11 destroys their GTPase activity 
and renders them constitutively active, even in the presence of a GAP [34]. GαqQL or Gα11QL were 
therefore expressed in JY1286 (∆mam2, ∆rgs1, ∆gpa1) in the presence of the different RGS 
proteins. Immunoblotting confirmed expression of all RGS proteins and GαqQL (Fig. 5A) or Gα11QL 
(Fig. 5B) before the level of signalling was determined as previously, from 0% in the absence of 
GαQL to 100% in the presence of GαQL but absence of an RGS (Fig. 5C). In contrast to the results 
with the wild-type Gα subunits, only RGS2 and RGS3 caused a marked reduction in signalling by 
the constitutively active mutants. RGS1 and RGS4 were unable to exert an inhibitory effect in a 
setting where they could not act as GAPs. Furthermore, neither RGS5 nor RGS16 were able to 
reduce signalling through GαqQL. 
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3.5 GPCR-mediated activation of human Gα subunits - To determine if RGS-Gαq/Gα11 specificity 
was maintained under conditions of GPCR stimulation, we coupled the human subunits to the yeast 
pheromone receptor. The yeast strain JY1287 lacks Gpa1 and Rgs1 but contains the Mam2 receptor. 
Expressing Gpa1 in JY1287 recreates a functional signalling pathway but, in contrast to the earlier 
situation in which Gpa1 expression in JY1286 (∆mam2, ∆rgs1, ∆gpa1) increased the median cell 
volume to ~95 fl (Fig. 2C), the cell volume remained at ~63 fl (Fig. 6). Presumably, the presence of 
the receptor in JY1287 ensures that the expressed Gpa1 is maintained in the inactive conformation. 
Stimulation with P-factor activated the morphology-response pathway, increasing the cell volume to 
~95 fl. 
 In contrast to Gpa1, neither Gαq nor Gα11 coupled to the Mam2 receptor and their 
spontaneous activation of the pheromone-response pathway produced cells with a volume of ~85 fl 
and ~83 fl, respectively (Fig. 6). There was no further increase in cell volume following exposure to 
mating pheromone, again consistent with the failure of the human Gα subunits to couple to the 
receptor. GPCR-Gα interactions can be specific and a given Gα subunit does not necessarily 
interact with all receptors. One of the major factors determining whether a GPCR will couple to a G 
protein involves the C-terminus of the Gα. Switching as few as 5 amino acids from one subunit to 
another can have dramatic effects on which receptors couple to a particular G protein [35]. These 
Gα-transplants have previously been used to alter the coupling specificity of the Sz. pombe Gα 
subunit [15]. We therefore created the reciprocal human-yeast transplants, in which the last 5 
residues of Gpa1 (QSLMF) were used to replace the equivalent residues of Gαq (EYNLV) and 
Gα11 (also EYNLV). JY1287 cells expressing the modified constructs, Gαq[5C] and Gα11[5C], were 
smaller than those expressing the unmodified human Gα subunits, and were approximately the 
same size as cells expressing the endogenous Gpa1. This would suggest that the Gα[5C]-transplants 
couple to the Mam2 receptor and there is a concomitant reduction in their spontaneous activation of 
the response pathway. Consistent with this, pheromone stimulation of these cells induced shmoo 
formation (Fig. 6), suggesting that the Gα[5C]-transplants were able to interact with the Mam2 
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receptor and activate downstream signalling components. Immunoblotting confirmed that the 
Gα[5C]-transplants were expressed to equivalent levels as for wild type Gαq and Gα11. 
 To examine the ability of the different RGS proteins to regulate receptor-activated Gαq[5C] and 
Gα11[5C], the various Gα-RGS combinations were expressed in JY1287 (∆gpa1, ∆rgs1). 
Immunoblotting confirmed expression of each RGS protein with either Gαq[5C] (Fig. 7A) or Gα11[5C] 
(Fig. 7B) before median cell volumes in the presence of low-level stimulation (10-8 M P-factor) or 
high-level stimulation (10-6 M) were determined (Fig. 7C and 7D). The pattern of activity of the 
RGS proteins at low-level stimulation was similar to that observed for the wild-type Gα subunits in 
strains lacking the receptor (compare Fig. 7C with Fig. 4E); all of the R4 proteins reduced 
signalling by Gαq[5C], but only RGS1, RGS2, RGS3 and RGS4 reduced signalling by Gα11[5C] as 
RGS5 had only partial effects and RGS16 had almost no effect. Neither Gαq[5C] nor Gα11[5C] were 
inhibited by RGS20. The pattern of activity of the RGS proteins at high-level stimulation was 
similar to that observed for the constitutively active GαQL subunits (compare Fig. 7D with Fig. 5C); 
signalling was most reduced by RGS2 and RGS3, although the difference between these and other 
RGS proteins was less distinct than for GαQL. 
 
4. DISCUSSION 
4.1 Human Gα subunits and RGS proteins function in Sz. pombe - Our results demonstrate that 
human Gαq and Gα11, along with members of the R4 family of RGS proteins, are active in Sz. 
pombe. In strains lacking the pheromone receptor and Rgs1, an RGS protein that normally reduces 
Gα signalling, the human subunits activate the morphology-response pathway (shmoo formation) 
usually regulated by Gpa1 (Fig. 2). In Sz. pombe both the receptor [15,24] and RGS protein [14] 
reduce Gpa1 signalling, and we presume that removing these negative regulators increases the rate 
at which Gα subunits become spontaneously activated to Gα-GTP. Consistent with this suggestion, 
the activity of both Gαq and Gα11 was dependent upon binding of GTP and reduced by expression 
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of Rgs1 (Fig. 3). Replacement of Rgs1 with human members of the R4 family of RGS proteins 
enabled determination of RGS-Gαq and RGS-Gα11 specificity under a number of activating 
conditions. 
 
4.2 Differences in activity between the human Gα subunits and Gpa1  - Although the human Gα 
subunits were able to activate the morphology-response pathway, they were unable to induce the 
pheromone-dependent transcription pathway. In contrast, endogenous Gpa1 activates both pathways 
(Fig. 1). The pathways separate immediately downstream of Ras1, a homologue of the mammalian 
RAS proto-oncoprotein. Like Gα subunits, Ras1 functions as a molecular switch, with a GTP-
bound 'on' state and a GDP-bound 'off' state, in a cycle that is regulated by guanine-nucleotide 
exchange factors (GEFs) and GAPs. The ability of Ras1 to activate the different effectors, Byr2 and 
Scd1, is regulated by different GEFs; Ste6 directs it to the transcription-response pathway while 
Efc25 directs it towards the morphology response. The functions of Ste6 and Efc25 are not 
interchangeable. Indeed, the two appear to act in competition [36] and this might explain how Ras1 
is regulated.  
Our results suggest that, whereas Gpa1 can activate both Byr2 and Scd1, Gαq and Gα11 are 
unable to interact with Ras1 to activate the transcription-response pathway. The most likely 
explanation is that the human Gα subunits lack the structural requirements to create a productive 
Gα-Ras1-Byr2 interaction. Identifying these regions will not be straightforward, as effector 
domains are usually a feature of the folded Gα subunit, and the contributing residues are often 
distributed throughout the protein [37,38]. 
 
4.3 The involvement of Gβγ subunits - An interesting aspect of our study concerns the involvement, 
or otherwise, of a Gβγ dimer. Sz. pombe expresses a single Gβ subunit, Gpb1/Git5 [39,40], and a 
single Gγ subunit, Git11 [37]. Despite claims to the contrary [39], the Git5-Git11 dimer does not 
interact with Gpa1 but is the Gβγ partner for a second Gα subunit, Gpa2, involved in the glucose-
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sensing pathway [41]. The Sz. pombe genome does not appear to encode any other Gβγ subunits 
that could interact with Gpa1, but this does not preclude the possibility that Gpa1 interacts with 
other partners. For example, in Sc. cerevisiae, the GPA2 subunit interacts with one of two kelch-
repeat proteins and a single Gγ-like subunit [42]. The resulting complexes have some, but not all, of 
the properties of Gαβγ heterotrimers.  
 The human Gα subunits in this study obviously do not have access to their normal Gβγ 
partners (these are absent from our strains) and it will be interesting to discover whether they hijack 
the Git5-Git11 subunits from the glucose-sensing pathway or whether they interact with some other 
Gβγ-like partners in the yeast. Alternatively, the human Gα subunits may be operating as 
monomers, a result that would have wide ranging repercussions for G protein signalling in higher 
eukaryotes. 
 
4.4 Selectivity of human RGS proteins - Consistent with results in vitro and in mammalian cells 
[32], we find that RGS1, RGS2, RGS3 and RGS4 exert an inhibitory effect on both Gαq- and Gα11-
mediated signalling (Fig. 4). In contrast, RGS20, which is highly selective for Gαz [3], has no effect 
on either Gα subunit. These results suggest that the specificity of Gα-RGS interactions in yeast is 
broadly similar to that in mammalian cells. 
 Interestingly, our results suggest that RGS16 and, to a lesser extent, RGS5 are more effective 
against Gαq than Gα11 at the expression levels achieved in our strains. The ability of these two RGS 
proteins to inhibit Gαq-mediated signalling is well documented [43-45] but their reduced effect on 
Gα11-mediated signalling has not been described previously. Gαq and Gα11 are structurally similar, 
sharing 89% of their amino acid residues, and are often considered to have similar activities. 
However, although they share the ability to activate phospholipase-Cβ, they can differ in tissue 
distribution and ability to interact with downstream effectors and adaptors [4]. Few studies have 
attempted to investigate these differences at the molecular level. An exception is the activation of 
Gαq, but not Gα11, by the Pasteurella multocida  toxin (PMT), which is due to the interaction of the 
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toxin with residues 105-113 of Gαq [46,47]. Identifying which regions are responsible for the 
interactions between Gαq/Gα11 and RGS5/RGS16 will be a challenge as multiple residues 
throughout the RGS-Gα interface are likely to be involved. Our Sz. pombe strains will provide the 
ideal system in which to perform these studies. 
 To further investigate the mechanism of action of the various RGS proteins, we assayed their 
effects against constitutively active Gα subunits lacking GTPase activity (Fig. 5). RGS1, RGS4, 
RGS5 and RGS16 were much less effective at reducing signalling through the constitutively active 
GαQL subunits than the wild-type, suggesting that their inhibitory properties rely on GAP activity. 
In contrast, and in accordance with results seen in COS-7 cells [48], RGS2 and RGS3 reduced 
signalling from both GαqQL and Gα11QL. This suggests that they do not rely entirely on GAP activity 
and other mechanisms, such as effector antagonism, are sufficient to mediate their inhibitory 
effects. This difference in the mode of action of RGS2 and RGS3 to other members of the R4 
subfamily has also been observed in mammalian cells [48,49]. 
 Small changes to the C-terminus of the human Gα subunits enabled them to couple to an 
endogenous receptor. We utilised these modified subunits to compare the effects of the different 
RGS proteins on Gα signalling under conditions of low and high stimulation with pheromone (Fig. 
7). The pattern of activity for the RGS proteins at low-level stimulation was remarkably similar to 
that observed for the spontaneously active Gα subunits, and the pattern at high-level stimulation 
was similar to that observed for the constitutively active GαQL subunits (compare Fig. 7C and 4E, 
and Fig. 7D and 5C). A simple explanation could be that the activity of Gα subunits at low-level 
stimulation is reduced by RGS proteins acting as GAPs, but that the reduction of signalling at high 
levels of stimulation requires the RGS proteins to have additional inhibitory functions, such as 
effector antagonism. It will be interesting to investigate this aspect further. 
While this study has demonstrated RGS-Gα specificity, it remains poorly understood how 
RGS proteins target particular activated signalling cascades in vivo. Evidence has suggested a 
potential role for the activated GPCR in this process [50,51]. Since non-yeast GPCRs have been 
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demonstrated to function in Sz. pombe [15], our next challenge will be to generate yeast cells that 
express a complete mammalian signalling unit (GPCR-Gα-RGS). These strains should greatly 
contribute to our understanding of the complex interactions that occur between these three 
signalling components. 
 
5. CONCLUSION 
It has previously been demonstrated that certain members of the B/R4 family (RGS4-like) of 
RGS proteins are able to modulate Gαq signalling in vitro [4]. Our studies have extended this 
research by investigating the ability of these RGS protein to attenuate Gαq and Gα11 signalling in 
vivo. By using a model yeast system, where it is possible to express individual RGS-Gα 
combinations, we have demonstrated that two specific RGS proteins (RGS5 and RGS16) are able to 
discriminate between these highly related Gα subunits. This represents the first demonstration of 
RGS-Gα selectivity between these two members of the Gαq subfamily of G proteins. Since many 
GPCRs couple to Gαq/Gα11 our results could provide a mechanism for selectively modulating the 
stimulated GPCRs. Expression of different Gα and RGS combinations, within our yeast cells, 
should provide further insights into the selectivity that RGS proteins display for specific G proteins. 
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FIGURE LEGENDS 
 
Fig. 1. Signalling pathways that regulate mating responses in Sz. pombe. Mating responses are 
initiated by the binding of the mating pheromones to receptors on the surface of target cells (23); P-
factor binds to a 7-span receptor, on the cell surface, that is coupled to the Gα subunit Gpa1. 
Pheromone stimulation leads to the formation of Gpa1-GTP. One target for Gpa1-GTP is the 
mitogen-activated protein (MAP) kinase cascade comprised of Byr2 (a MAP kinase kinase kinase 
[MAP3K]), Byr1 (a MAP2K), and Spk1 (a MAPK). Substrates of Spk1 include the Ste11 
transcription factor that regulates the expression of proteins required for mating. Gpa1-GTP also 
activates a second signalling pathway, by activation of Scd1, a protein which is involved in 
controlling cell morphology. Both the transcription and morphology pathways are mediated by 
Ras1. Signalling is terminated within these cells by the action of a number of proteins including 
Rgs1, a GTPase-activating protein for Gpa1. 
 
Fig. 2. Assays for Gα activity. A, JY1286 cells (∆mam2, ∆gpa1, ∆rgs1, sxa2>lacZ) were 
transformed with pREP3X constructs containing the Sz. pombe Gpa1 or human Gαq and Gα11 
subunits under the control of the thiamine-repressible nmt1  promoter. Cells grown in the presence 
(repressed, nmt1 promoter is off) or absence (induced, nmt1 promoter is on) of thiamine were 
assayed for β-galactosidase activity (16). Data shown are averages of duplicate determinations of 
three independent isolates (± SD). Expression of Gαq and Gα11 was monitored by immunoblotting 
using a monoclonal rabbit anti-Gαq/11. B, JY1286 cells (∆mam2, ∆gpa1, ∆rgs1) expressing Gαq or 
Gα11 from the pREP3X vector were grown in the presence (repressed) or absence (induced) of 
thiamine. The elongated cell morphology is reminiscent of the shmoo formation observed when 
wild-type Sz. pombe cells are exposed to mating pheromone (19). C, JY1286 cells (∆mam2, ∆gpa1, 
∆rgs1) transformed with pREP3X constructs containing the Sz. pombe Gpa1, human Gαq or human 
Gα11 were grown in the presence (repressed) or absence (induced) of thiamine. Median cell 
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volumes were determined using a Coulter Channelyser (19) and the results shown are averages of 
duplicate determinations of three independent isolates (± SD). Cells containing the empty pREP3X 
vector (No Gα) provided a control for the effects of thiamine on cell volume. 
 
Fig. 3. Signalling requires GTP exchange and is inhibited by RGS activity. Mutant Gα subunits 
expressed in JY1286 (∆mam2, ∆gpa1, ∆rgs1) from the pREP3X vector were assayed for their 
ability to activate the transcription response (A - Gpa1) and/or the morphology response (B - Gpa1; 
C - Gαq; D - Gα11). Mutation of a conserved glycine in the switch II region inhibits the release of 
GDP and locks the Gα in an inactive form (GαIN). The effects of co-expression of the Sz. pombe 
Rgs1 protein (from the pREP4X vector) on the activity of wild-type Gα subunits and mutant Gα 
subunits, in which mutation of a glycine in the switch I region blocks the interaction with RGS 
proteins (Gαrgs), were also monitored. Median cell volumes were determined using a Coulter 
Channelyser and the results shown are averages of duplicate determinations of three independent 
isolates (± SD). 
 
Fig. 4. Effects of different RGS (R4) proteins on Gαq and Gα11 signalling. JY1286 cells (∆mam2, 
∆gpa1, ∆rgs1) expressing (A) Gαq or (B) Gα11 from pREP3X, were transformed with pREP4X 
constructs directing the expression of various RGS proteins. Expression of Gαq or Gα11 was 
monitored by immunoblotting using a monoclonal rabbit anti-Gαq/11, while expression of individual 
RGS proteins was determined by using antibodies specific to the relevant RGS protein. Median 
volumes of cultures grown in the absence of thiamine (to induce expression of both the Gα and 
RGS proteins) were determined using a Coulter Channelyser, (C) Gαq or (D) Gα11, and the results 
shown are averages of duplicate determinations of three independent isolates (± SD). (E) - 
comparison of the different Gα-RGS combinations. Results were normalised such that the median 
cell volume in the absence of a Gα subunit was set at 0% Gα signalling, and the median cell 
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volume in the presence of the Gα but the absence of an RGS was set at 100% Gα signalling 
(dashed lines highlighting 10%, 50% and 100% signalling are included to aid comparison). Data in 
(E) are from the average values in (C) and (D). 
 
Fig. 5. Effects of RGS (R4) proteins on signalling by constitutively active Gα subunits. JY1286 
cells (∆mam2, ∆gpa1, ∆rgs1) expressing constitutively active versions of Gαq or Gα11 (contain the 
Gln209Leu mutation within the switch II region) from pREP3X were transformed with pREP4X 
constructs directing the expression of various RGS proteins. Expression of (A) GαqQL and (B) 
Gα11QL was monitored by immunoblotting using a monoclonal rabbit anti-Gαq/11, while expression 
of individual RGS proteins was determined as for Fig. 4. (C) - median volumes of cultures grown in 
the absence of thiamine (to induce expression of both the GαQL and RGS proteins) were determined 
using a Coulter Channelyser. The signalling activity of each GαQL-RGS combination was 
determined as in Fig. 4.  
 
Fig. 6. Receptor-dependent stimulation of Gαq and Gα11. JY1287 cells (∆gpa1, ∆rgs1, but express 
the Mam2 pheromone receptor) were transformed with pREP3X constructs expressing Gpa1, Gαq, 
Gα11 or modified human subunits containing the last 5 residues of the Sz. pombe Gpa1 (Gα[5C]). 
Expression of Gαq/Gαq[5C] and Gα11/Gα11[5C] was monitored by immunoblotting using individual 
monoclonal rabbit anti-Gαq or anti- Gα11 respectively each generated to a central portion of the 
proteins. Cells were grown in thiamine-free medium and exposed to P-factor mating pheromone for 
16 h. Median cell volumes were determined using a Coulter Channelyser and the results shown are 
averages of duplicate determinations of three independent isolates (± SD). 
 
Fig. 7. Effects of RGS (R4) proteins on receptor-dependent Gαq and Gα11 activity. JY1287 cells 
(∆gpa1, ∆rgs1, but express the Mam2 pheromone receptor) expressing (A) Gαq[5C] and (B) Gα11[5C] 
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from pREP3X were transformed with pREP4X constructs directing the expression of various RGS 
proteins. Cells were grown in thiamine-free medium and exposed to P-factor mating pheromone for 
16 h; (C) low (10-8 M P-factor), (D) high (10-6 M). Median cell volumes were determined using a 
Coulter Channelyser and the signalling activity of each Gα-RGS combination was determined as in 
Fig. 4. Expression of Gαq[5C] and Gα11[5C] was monitored as for Fig. 6, while expression of 
individual RGS proteins was determined as for Fig. 4. 
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